{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Jocil Ltd
Jocil Ltd Gains 4.51%: 3 Key Factors Driving the Weekly Move
Jocil Ltd’s stock advanced by 4.51% over the week ending 6 February 2026, outperforming the Sensex’s 1.51% gain. The week was marked by a rebound from early losses, positive quarterly financial trends, and a valuation reset that improved the stock’s attractiveness despite lingering margin pressures and liquidity concerns.
Why is Jocil Ltd falling/rising?
On 06-Feb, Jocil Ltd's stock price edged higher by 0.43% to ₹131.99, reflecting a modest recovery despite persistent long-term challenges and underperformance relative to broader market indices.
Jocil Ltd Valuation Shifts to Fair; P/E and P/BV Signal Improved Price Attractiveness
Jocil Ltd, a player in the Chemicals & Petrochemicals sector, has witnessed a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. This change, driven primarily by adjustments in its price-to-earnings (P/E) and price-to-book value (P/BV) ratios, marks a significant development for investors assessing the stock’s price attractiveness against historical and peer benchmarks.
Jocil Ltd Reports Positive Quarterly Financial Trend Amid Lingering Market Challenges
Jocil Ltd, a player in the Chemicals & Petrochemicals sector, has demonstrated a notable turnaround in its financial trend for the quarter ended December 2025. After a period of stagnation, the company’s financial performance has shifted from flat to positive, driven by improved profitability despite liquidity concerns. This development comes amid a broader market environment where the stock has underperformed the Sensex over multiple time horizons.
Are Jocil Ltd latest results good or bad?
Jocil Ltd's latest results show mixed performance, with a sequential decline in net sales and profit, but a year-on-year increase in both. While operating margins have slightly improved, the company faces ongoing challenges in profitability and capital efficiency.
Jocil Ltd Q2 FY26: Margin Pressures Mount Despite Revenue Growth
Jocil Limited, a micro-cap chemicals manufacturer and subsidiary of Andhra Sugars Limited, reported a net profit of ₹1.87 crores for Q2 FY26, marking a decline of 15.77% quarter-on-quarter but an improvement of 62.61% year-on-year. With a market capitalisation of ₹111.00 crores, the company operates in the manufacture of stearic acid, fatty acids, refined glycerine, soap noodles, and industrial oxygen, alongside power generation from biomass and wind sources.
Jocil Ltd is Rated Sell
Jocil Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial data presented here reflect the stock's current position as of 29 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Jocil Ltd is Rated Sell by MarketsMOJO
Jocil Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 August 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 January 2026, providing investors with the latest insights into the company's performance and outlook.
Jocil Ltd is Rated Sell
Jocil Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 05 Aug 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 December 2025, providing investors with an up-to-date view of the company’s performance and outlook.
Jocil Sees Revision in Market Evaluation Amid Mixed Financial Indicators
Jocil, a microcap player in the Chemicals & Petrochemicals sector, has experienced a revision in its market evaluation metrics, reflecting nuanced shifts across key financial and technical parameters. This adjustment comes amid a backdrop of subdued stock performance and sector-specific challenges.
Is Jocil overvalued or undervalued?
As of November 3, 2025, Jocil is considered overvalued with a PE ratio of 70.49 and an EV to EBIT of 62.69, significantly higher than its peers, and has underperformed the Sensex with a return of -24.41% over the past year.
How has been the historical performance of Jocil?
Jocil's historical performance shows fluctuating sales, with net sales rising to 865.54 Cr in Mar'25 but declining profitability, as profit after tax fell to 1.02 Cr from 1.73 Cr in Mar'24. Total assets increased to 287.67 Cr, but cash flow from operations decreased to 10.00 Cr in Mar'25.
Are Jocil latest results good or bad?
Jocil's latest Q2 FY26 results show a mixed performance with a 6.98% year-on-year increase in net sales but an 8.95% decline from the previous quarter, alongside a significant year-on-year profit increase of 62.61% that still fell 15.77% sequentially. Overall, the company faces challenges in sustaining profitability and generating shareholder returns, indicating a complex operational landscape.
Jocil Faces Financial Health Challenges Amidst Mixed Earnings Performance and Market Disparities
Jocil, a microcap in the Chemicals and Petrochemicals sector, reported a flat performance for the quarter ending September 2025. Despite a higher profit after tax of Rs 4.09 crore, challenges remain with low operating cash flow and a dividend per share of Rs 0.50, indicating operational inefficiencies.
Jocil Q2 FY26: Margin Pressures Persist Despite Revenue Growth
Jocil Ltd., a specialty chemicals manufacturer engaged in stearic acid, fatty acids, and refined glycerine production, reported a mixed performance for Q2 FY26, with net profit declining 15.77% quarter-on-quarter to ₹1.87 crores despite revenue growth. The Andhra Pradesh-based company, with a market capitalisation of ₹135.00 crores, continues to grapple with margin compression that has plagued its operations throughout FY25. The stock has declined 23.71% over the past year, significantly underperforming both the Sensex and its chemicals sector peers, whilst trading at elevated valuations that raise serious questions about its investment merit.
Why is Jocil falling/rising?
As of 18-Sep, Jocil Ltd's stock price is at 154.04, down 1.36%, and has underperformed its sector. The stock shows long-term challenges with significant declines in operating profit and returns, indicating poor growth prospects and cautious investor sentiment.
Jocil Reports Record Sales Amid Mixed Financial Performance and Market Challenges
Jocil, a microcap in the Chemicals and Petrochemicals sector, reported strong quarterly results for June 2025, achieving record net sales and profit figures. However, its profit after tax has declined over the past six months. The company's stock has shown resilience despite mixed performance compared to the Sensex.
How has been the historical performance of Jocil?
Jocil's historical performance shows fluctuating financial metrics, with net sales rising from INR 446.25 crore in March 2020 to INR 865.54 crore in March 2025, but declining profits and EPS, with profit after tax dropping from INR 12.49 crore to INR 1.02 crore in the same period. Total liabilities and assets increased, while cash flow from operating activities improved.
What does Jocil do?
Jocil Ltd, a subsidiary of Andhra Sugars, manufactures chemical products like Stearic Acid and Fatty Acids, with a market cap of INR 148 Cr and reported net sales of 1,782 Cr and a net profit of 4 Cr for March 2025. The company is classified as a Micro Cap in the Chemicals & Petrochemicals industry.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
